283 filings
Page 13 of 15
6-K
ngyocy3urf ja
21 Oct 14
Kamada Announces Study in Support of Alpha-1 Antitrypsin for the Treatment
12:00am
6-K
qtgbpoo
9 Oct 14
Current report (foreign)
12:00am
6-K
uhbj5968 yxmj2
6 Oct 14
Current report (foreign)
12:00am
6-K
ghu07ayenwdcl
29 Sep 14
Kamada Announces Second Extension of Strategic Agreement with Baxter
12:00am
6-K
bwga19wc 9lgz
10 Sep 14
Current report (foreign)
12:00am
6-K
hz9m37wpr7sk sl
4 Sep 14
Kamada Reports Final Results from Phase 2/3 Clinical Trial of Inhaled Alpha-1
12:00am
6-K
tg5s6f2jd36ufdfpv4
3 Sep 14
Kamada to Announce Final Results from Phase 2/3 Clinical Trial of Inhaled AAT
12:00am
6-K
qjg 7tfdlzv
18 Aug 14
Current report (foreign)
12:00am
6-K
s7ruc
14 Aug 14
Kamada Reports Second Quarter Financial Results
12:00am
6-K
nlq8m3nkepkfo1
23 Jun 14
Current report (foreign)
12:00am
6-K
n6n9cl2g
5 Jun 14
Current report (foreign)
12:00am
6-K
as595ig dc3yrgazd11i
16 May 14
Kamada Announces Preliminary Results from Phase II/III Pivotal Trial in Europe
12:00am
6-K
cl8lsph4ae
15 May 14
Current report (foreign)
12:00am
6-K
wbmrn97eh1gx5oh jn
15 May 14
Kamada to Announce Results from Phase 2/3 Clinical Trial of Inhaled AAT to
12:00am
6-K
ohvbm5hvgkbs32b4m
15 May 14
Current report (foreign)
12:00am
6-K
yu36ksa5x llt
12 May 14
Current report (foreign)
12:00am
6-K
4kye rlt1fm43gmm
8 May 14
Kamada Reports First Quarter Financial Results
12:00am
6-K
5zueevhn asw9w4s
24 Apr 14
Lowers time from preparation to finish for patients with Alpha-1 Antitrypsin
12:00am
6-K
jizdkiz0y1p
3 Apr 14
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease
12:00am
6-K
tbx0y3 b2timxhnnje
26 Mar 14
Israeli Securities Law Regulations (Periodic and Immediate Reports) 9d
12:00am